These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25892887)

  • 1. Efficacy of S-1 vs capecitabine for the treatment of gastric cancer: a meta-analysis.
    He AB; Peng XL; Song J; Zhang JX; Dong WG; Luo RF; Tang Y
    World J Gastroenterol; 2015 Apr; 21(14):4358-64. PubMed ID: 25892887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.
    He MM; Wu WJ; Wang F; Wang ZQ; Zhang DS; Luo HY; Qiu MZ; Wang FH; Ren C; Zeng ZL; Xu RH
    PLoS One; 2013; 8(12):e82798. PubMed ID: 24349363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of S-1-based vs. capecitabine-based adjuvant chemotherapy for patients with gastric cancer: a systematic review and meta-analysis.
    Zhang Q; Qian Y; Yin Y
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1791-1804. PubMed ID: 34275019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of capecitabine-based versus S-1-based chemotherapy for metastatic or recurrent gastric cancer: a systematic review and meta-analysis of clinical randomized trials.
    Feng Z; Yan P; Hou X; Feng J; He X; Yang K
    Ann Palliat Med; 2020 May; 9(3):883-894. PubMed ID: 32389017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multicenter clinical study for the comparison of S-1 versus capecitabine in the treatment of advanced breast cancer].
    Li Y; Jiang D; Wu YY; Li LL; Cui YZ; Dong Q
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):607-612. PubMed ID: 28835084
    [No Abstract]   [Full Text] [Related]  

  • 6. S-1-based combination therapy vs S-1 monotherapy in advanced gastric cancer: a meta-analysis.
    Liu GF; Tang D; Li P; Wang S; Xu YX; Long AH; Zhou NL; Zhang LL; Chen J; Xiang XX
    World J Gastroenterol; 2014 Jan; 20(1):310-8. PubMed ID: 24415887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of efficacy and safety of S-1 and capecitabine in patients with metastatic colorectal carcinoma: A systematic review and meta-analysis.
    Chen J; Wang J; Xu T
    Medicine (Baltimore); 2019 Jul; 98(30):e16667. PubMed ID: 31348323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term efficacy of different chemotherapy regimens in the treatment of advanced gastric cancer: a network meta-analysis.
    Duo-Ji MM; Ci-Ren BS; Long ZW; Zhang XH; Luo DL
    Oncotarget; 2017 Jun; 8(23):37896-37911. PubMed ID: 28099947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of gastric cancer in Asia: the missing link.
    Nishida T
    Lancet Oncol; 2009 Nov; 10(11):1027-8. PubMed ID: 19880057
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized phase II study of S-1 versus capecitabine as first-line chemotherapy in elderly metastatic gastric cancer patients with or without poor performance status: clinical and pharmacogenetic results.
    Kim MJ; Kong SY; Nam BH; Kim S; Park YI; Park SR
    Pharmacogenet Genomics; 2018 Jan; 28(1):23-30. PubMed ID: 29189588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.
    Boku N; Yamamoto S; Fukuda H; Shirao K; Doi T; Sawaki A; Koizumi W; Saito H; Yamaguchi K; Takiuchi H; Nasu J; Ohtsu A;
    Lancet Oncol; 2009 Nov; 10(11):1063-9. PubMed ID: 19818685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of S-1-based and capecitabine-based regimens in gastrointestinal cancer: a meta-analysis.
    Zhang X; Cao C; Zhang Q; Chen Y; Gu D; Shen Y; Gong Y; Chen J; Tang C
    PLoS One; 2014; 9(1):e84230. PubMed ID: 24392116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-1-based vs non-S-1-based chemotherapy in advanced gastric cancer: a meta-analysis.
    Yang J; Zhou Y; Min K; Yao Q; Xu CN
    World J Gastroenterol; 2014 Sep; 20(33):11886-93. PubMed ID: 25206296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer.
    Wu FL; Lu DC; Ying YP; Huang JJ; Zhou AM; Jiang DK; Chen MW; Yang X; Zhou J; Huang HQ; Zeng HY
    Medicine (Baltimore); 2015 Apr; 94(16):e652. PubMed ID: 25906091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.
    Koizumi W; Narahara H; Hara T; Takagane A; Akiya T; Takagi M; Miyashita K; Nishizaki T; Kobayashi O; Takiyama W; Toh Y; Nagaie T; Takagi S; Yamamura Y; Yanaoka K; Orita H; Takeuchi M
    Lancet Oncol; 2008 Mar; 9(3):215-21. PubMed ID: 18282805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysis.
    Bian NN; Wang YH; Min GT
    Int J Surg; 2019 Feb; 62():34-43. PubMed ID: 30641155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of S-1 in the treatment of gastric cancer.
    Kubota T
    Br J Cancer; 2008 Apr; 98(8):1301-4. PubMed ID: 18362933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    Lee JL; Kang YK; Kang HJ; Lee KH; Zang DY; Ryoo BY; Kim JG; Park SR; Kang WK; Shin DB; Ryu MH; Chang HM; Kim TW; Baek JH; Min YJ
    Br J Cancer; 2008 Aug; 99(4):584-90. PubMed ID: 18665164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility study of supportive care using lafutidine, a histamine H2 receptor antagonist, to prevent gastrointestinal toxicity during chemotherapy for gastric cancer.
    Namikawa T; Munekage E; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Anticancer Res; 2014 Dec; 34(12):7297-301. PubMed ID: 25503163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
    Sakuramoto S; Sasako M; Yamaguchi T; Kinoshita T; Fujii M; Nashimoto A; Furukawa H; Nakajima T; Ohashi Y; Imamura H; Higashino M; Yamamura Y; Kurita A; Arai K;
    N Engl J Med; 2007 Nov; 357(18):1810-20. PubMed ID: 17978289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.